Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Equities
TEVA
IL0006290147
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,933 ILa | +0.98% | -0.90% | +29.31% |
Sales 2024 * | 15.86B 6,039B 1,323B | Sales 2025 * | 16.35B 6,223B 1,363B | Capitalization | 15.64B 5,955B 1,304B |
---|---|---|---|---|---|
Net income 2024 * | 1.54B 586B 128B | Net income 2025 * | 1.44B 549B 120B | EV / Sales 2024 * | 1.91 x |
Net Debt 2024 * | 14.62B 5,567B 1,219B | Net Debt 2025 * | 12.12B 4,613B 1,010B | EV / Sales 2025 * | 1.7 x |
P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
10.3
x | Employees | 35,737 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
1 day | +0.98% | ||
1 week | -0.90% | ||
Current month | -4.64% | ||
1 month | -4.14% | ||
3 months | +13.40% | ||
6 months | +47.87% | ||
Current year | +29.31% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/23/01 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/19/22 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/15/01 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/20/09 |
Sol Barer
CHM | Chairman | 76 | 01/15/01 |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 4,933 | +0.98% | 1,924,653 |
24/24/24 | 4,885 | +1.14% | 1,186,722 |
21/24/21 | 4,830 | -2.97% | 1,345,230 |
18/24/18 | 4,978 | +0.57% | 736,987 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 04:54 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- TEVA Stock
- TEVA Stock